ABEO - アビオナ・セラピュ―ティクス (Abeona Therapeutics Inc.)

ABEOのニュース

   Abeona Therapeutics tp raise $25M in convertible preferred stock offering  2022/04/29 12:13:03 Seeking Alpha
Abeona Therapeutics (ABEO) entered into a securities purchase agreement with certain institutional investors to purchase 1M shares of Series A convertible redeemable preferred stock…
   Abeona Therapeutics Announces Strategy Update and 2021 Financial Results By Investing.com  2022/03/31 12:06:02 Investing.com
Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
   Abeona Therapeutics GAAP EPS of -$0.45 beats by $0.15, revenue of $3M  2022/03/31 12:02:34 Seeking Alpha
Abeona Therapeutics press release (ABEO): FY GAAP EPS of -$0.45 beats by $0.15.Revenue of $3M (flat Y/Y).Cash, cash equivalents, restricted cash and short-term investments totaled…
   Abeona Therapeutics Inc. (NASDAQ:ABEO) Lost -4.43% In A Week: What’s Driving The Stock?  2022/03/18 13:00:00 Marketing Sentinel
In last trading session, Abeona Therapeutics Inc. (NASDAQ:ABEO) saw 1.28 million shares changing hands with its beta currently measuring 1.25. Company’s recent per share price level of $0.30 trading at $0.02 or 8.71% at ring of the bell on the day assigns it a market valuation of $30.74M. That closing price of ABEO’s stock is … Abeona Therapeutics Inc. (NASDAQ:ABEO) Lost -4.43% In A Week: What’s Driving The Stock? Read More »
   Abeona reaches enrollment target in phase 3 trial of EB-101 for rare skin wound disorder  2022/03/14 15:05:06 Seeking Alpha
Abeona Therapeutics (ABEO) said it completed target enrollment for a Phase 3 study testing its drug candidate, EB-101, to treat recessive dystrophic epidermolysis bullosa ((RDEB)), a…
   Abeona Therapeutics Inc Shares Approach 52-Week Low - Market Mover  2022/01/15 04:33:32 Kwhen Finance
Abeona Therapeutics Inc (ABEO) shares closed today at 1.1% above its 52 week low of $0.27, giving the company a market cap of $27M. The stock is currently down 19.7% year-to-date, down 84.9% over the past 12 months, and down 94.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 41.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 5.4% lower than its 5-day moving average, 13.2% lower than its 20-day moving average, and 64.6% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1581.4% The company's stock price performance over the past 12 months lags the peer average by 926.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Abeona Therapeutics Inc Shares Close the Day 11.0% Higher - Daily Wrap  2021/12/25 23:17:39 Kwhen Finance
Abeona Therapeutics Inc (ABEO) shares closed today 11.0% higher than it did at the end of yesterday. The stock is currently down 77.0% year-to-date, down 79.1% over the past 12 months, and down 92.5% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $0.37 and as low as $0.27 this week.Shares closed 90.5% below its 52-week high and 33.9% above its 52-week low.Trading volume this week was 70.7% lower than the 10-day average and 15.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 789.4% The company's stock price performance over the past 12 months lags the peer average by 887.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Flashy Stock: Abeona Therapeutics Inc. (NASDAQ:ABEO), Enterprise Products Partners L.P. (NYSE:EPD)  2021/12/24 00:00:23 Stock Equity
Abeona Therapeutics Inc. (NASDAQ:ABEO) with the stream of 11.03% also noticed, India Enterprise Products Partners L.P. (NYSE:EPD) encountered a rapid change of 0.47% in the last hour of Thursdays trading The post Flashy Stock: Abeona Therapeutics Inc. (NASDAQ:ABEO), Enterprise Products Partners L.P. (NYSE:EPD) appeared first on Stocks Equity .
   Is Abeona Therapeutics Inc. (NASDAQ:ABEO), -1048.48% Below Its High, Poised For A Strong Recovery?  2021/12/23 15:00:00 Marketing Sentinel
In last trading session, Abeona Therapeutics Inc. (NASDAQ:ABEO) saw 4.47 million shares changing hands with its beta currently measuring 1.40. Companys recent per share price level of $0.33 trading at $0.0 or -1.15% at ring of the bell on the day assigns it a market valuation of $55.21M. That closing price of ABEOs stock is Is Abeona Therapeutics Inc. (NASDAQ:ABEO), -1048.48% Below Its High, Poised For A Strong Recovery? Read More »
   Hot Mover to Watch: Abeona Therapeutics Inc. (NASDAQ:ABEO), Xos, Inc. (NASDAQ:XOSWW)  2021/12/19 23:41:53 Stock Equity
Abeona Therapeutics Inc. (NASDAQ:ABEO) with the stream of -39.97% also noticed, India Xos, Inc. (NASDAQ:XOSWW) encountered a rapid change of -12.35% in the last hour of Fridays trading session. Abeona The post Hot Mover to Watch: Abeona Therapeutics Inc. (NASDAQ:ABEO), Xos, Inc. (NASDAQ:XOSWW) appeared first on Stocks Equity .
   Why This Abeona Therapeutics Analyst Is Turning Bullish After Q3 Print  2020/11/11 16:24:24 Benzinga
Abeona Therapeutics Inc’s (NASDAQ: ABEO ) stock does not reflect the company’s in-house manufacturing capabilities and pipeline, according to Cantor Fitzgerald. Latest Ratings for ABEO … Full story available on Benzinga.com
   Abeona Therapeutics Reports Third Quarter Financial Results  2020/11/09 21:05:00 GlobeNewswire
Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET
   The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings  2020/11/04 13:21:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) BioLineRx ADR Representing 15 Ord Shs (NASDAQ: BLRX )(reacted to positive readout for its stem cell therapy to treat cancer) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(reacted to its quarterly results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) ( reported strong results for the third quarter) Immunovant Inc (NASDAQ: IMVT ) Scholar Rock Holding Corp (NASDAQ: SRRK ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 3) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aprea Therapeutics Inc (NASDAQ: APRE ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Benitec Biopharma Inc (NASDAQ: BNTC ) Esperion Therapeutics Inc (NASDAQ: ESPR ) (reacted to its quarterly results) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Jaguar Health Inc (NASDAQ: JAGX ) Liminal BioSciences Inc (NASDAQ: LMNL ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Opthea Spon (NASDAQ: OPT ) Silence Therapeutics ADR (NASDAQ: SLN ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Bristol-Myers Squibb Says Antitrust Waiting Period For Proposed Myokardia Acquisition Expires Bristol-Myers Squibb Co (NYSE: BMY ) said the waiting period under the HSR Act in connection with its previously announced tender offer to acquire …
   Abeona Therapeutics (NASDAQ:ABEO) Stock Price Up 5.5%  2020/10/25 04:10:50 The Lincolnian
Abeona Therapeutics Inc (NASDAQ:ABEO) shares rose 5.5% during trading on Friday . The company traded as high as $1.37 and last traded at $1.34. Approximately 1,131,214 shares were traded during trading, a decline of 22% from the average daily volume of 1,453,268 shares. The stock had previously closed at $1.27. ABEO has been the topic […]
   The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut  2020/10/01 12:18:26 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Annexon Inc (NASDAQ: ANNX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) CTI BioPharma Corp (NASDAQ: CTIC ) I-Mab ADR (NASDAQ: IMAB ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) (the blank check company announced a business combination with oncology-focused Vincera Pharma) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PMV Pharmaceuticals Inc (NASDAQ: PMVP ) PPD Inc (NASDAQ: PPD ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Shockwave Medical Inc (NASDAQ: SWAV ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 30) Abeona Therapeutics Inc (NASDAQ: ABEO ) Alector Inc (NASDAQ: ALEC ) Jaguar Health Inc (NASDAQ: JAGX ) Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX ) Neos Therapeutics Inc (NASDAQ: NEOS ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Pandion Therapeutics Inc (NASDAQ: PAND ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA ) Theravance Biopharma Inc (NASDAQ: TBPH ) Tricida Inc (NASDAQ: TCDA ) Stocks In Focus Amag Reportedly Pursued By Apollo's Covis Pharma AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) shares surged higher after a Bloomberg report said Apollo Management's Covis Pharma unit is in advanced talks to buy Amag.

calendar